Lichtenstein, P, Yip, BH, Bjork, C, Pawitan, Y, Cannon, TD, Sullivan, PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet
2009; 373: 234–9.
Sullivan, PF, Kendler, KS, Neale, MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry
2003; 60: 1187–92.
Schizophrenia Working Group of the Psychiatric Genomics C.
Biological insights from 108 schizophrenia-associated genetic loci. Nature
2014; 511: 421–7.
Dieset, I, Djurovic, S, Tesli, M, Hope, S, Mattingsdal, M, Michelsen, A, et al. Upregulation of NOTCH4 gene expression in bipolar disorder. Am J Psychiatry
2012; 169: 1292–300.
Wirgenes, KV, Sonderby, IE, Haukvik, UK, Mattingsdal, M, Tesli, M, Athanasiu, L, et al. TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry
2012; 2: e112.
Wirgenes, KV, Tesli, M, Inderhaug, E, Athanasiu, L, Agartz, I, Melle, I, et al. ANK3 gene expression in bipolar disorder and schizophrenia. Br J Psychiatry
2014; 205: 244–5.
Li, M, Wang, Y, Zheng, XB, Ikeda, M, Iwata, N, Luo, XJ, et al. Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility. Schizophr Res
2012; 142: 200–5.
Steinberg, S, de Jong, S, Irish Schizophrenia Genomics, C, Andreassen, OA, Werge, T, Borglum, AD, et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia. Hum Mol Genet
2011; 20: 4076–81.
Kerner, B, Rao, AR, Christensen, B, Dandekar, S, Yourshaw, M, Nelson, SF. Rare genomic variants link bipolar disorder with anxiety disorders to creb-regulated intracellular signaling pathways. Front Psychiatry
2013; 4: 154.
Psychiatric GWAS Consortium Bipolar Disorder Working group.
Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nature Genet
2011; 43: 977–83.
Nezu, J, Oku, A, Jones, MH, Shimane, M. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase. Genomics
1997; 45: 327–31.
Monsalve, DM, Merced, T, Fernandez, IF, Blanco, S, Vazquez-Cedeira, M, Lazo, PA. Human VRK2 modulates apoptosis by interaction with Bcl-xL and regulation of BAX gene expression. Cell Death Dis
2013; 4: e513.
Blanco, S, Sanz-Garcia, M, Santos, CR, Lazo, PA. Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein. PLoS One
2008; 3: e1660.
Sanz-Garcia, M, Vazquez-Cedeira, M, Kellerman, E, Renbaum, P, Levy-Lahad, E, Lazo, PA. Substrate profiling of human vaccinia-related kinases identifies coilin, a Cajal body nuclear protein, as a phosphorylation target with neurological implications. J Proteomics
2011; 75: 548–60.
Helbig, I, Lowenstein, DH. Genetics of the epilepsies: where are we and where are we going?
Curr Opin Neurol
2013; 26: 179–85.
Andreassen, OA, Harbo, HF, Wang, Y, Thompson, WK, Schork, AJ, Mattingsdal, M, et al. Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci. Mol Psychiatry
2015; 20: 207–14.
Kendler, KS, Walsh, D. Schizophreniform disorder, delusional disorder and psychotic disorder not otherwise specified: clinical features, outcome and familial psychopathology. Acta Psychiatr Scand
1995; 91: 370–8.
Tesli, M, Espeseth, T, Bettella, F, Mattingsdal, M, Aas, M, Melle, I, et al. Polygenic risk score and the psychosis continuum model. Acta Psychiatr Scand
2014; 130: 311–7.
Andreassen, OA, Thompson, WK, Schork, AJ, Ripke, S, Mattingsdal, M, Kelsoe, J, et al. Improved detection of common variants associated with schizophrenia and bipolar disorder using pleiotropy-informed conditional false discovery rate. PLoS Genet
2013; 9: e1003455.
International Schizophrenia Consortium.
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature
2009; 460: 748–52.
Spitzer, RL, Williams, JB, Gibbon, M, First, MB. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry
1992; 49: 624–9.
Athanasiu, L, Mattingsdal, M, Kahler, AK, Brown, A, Gustafsson, O, Agartz, I, et al. Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res
2010; 44: 748–53.
Djurovic, S, Gustafsson, O, Mattingsdal, M, Athanasiu, L, Bjella, T, Tesli, M, et al. A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord
2010; 126: 312–6.
Hellemans, J, Mortier, G, De Paepe, A, Speleman, F, Vandesompele, J. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol
2007; 8: R19.
Purcell, S, Neale, B, Todd-Brown, K, Thomas, L, Ferreira, MA, Bender, D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet
2007; 81: 559–75.
Li, Y, Willer, CJ, Ding, J, Scheet, P, Abecasis, GR. MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol
2010; 34: 816–34.
Bohn, MJ, Babor, TF, Kranzler, HR. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J Stud Alcohol
1995; 56: 423–32.
Berman, AH, Bergman, H, Palmstierna, T, Schlyter, F. Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res
2005; 11: 22–31.
Kay, SR, Fiszbein, A, Opler, LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull
1987; 13: 261–76.
Rush, AJ, Gullian, CM, Basco, MR, Jarrett, RB, Trivedi, MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med
1996; 26: 477–86.
Endicott, J, Spitzer, RL, Fleiss, JL, Cohen, J. The Global Assessment Scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry
1976; 33: 766–71.
Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry
1978; 133: 429–35.
Li, J, Ji, L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity
2005; 95: 221–7.
Bergen, SE, O'Dushlaine, CT, Ripke, S, Lee, PH, Ruderfer, DM, Akterin, S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry
2012; 17: 880–6.
Wickham, H. ggplot2: Elegant Graphics for Data Analysis (1st edn). Springer, 2009.
Epicure Consortium, EMINet Consortium.
Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32. Hum Mol Genet
2012; 21: 5359–72.
Altamura, AC, Pozzoli, S, Fiorentini, A, Dell'osso, B. Neurodevelopment and inflammatory patterns in schizophrenia in relation to pathophysiology. Prog Neuropsychopharmacol Biol Psychiatry
2013; 42: 63–70.
Hope, S, Ueland, T, Steen, NE, Dieset, I, Lorentzen, S, Berg, AO, et al. Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res
2013; 145: 36–42.
Rimol, LM, Hartberg, CB, Nesvag, R, Fennema-Notestine, C, Hagler, DJ Jr, Pung, CJ, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry
2010; 68: 41–50.
Simonsen, C, Sundet, K, Vaskinn, A, Birkenaes, AB, Engh, JA, Faerden, A, et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull
2011; 37: 73–83.
Sullivan, PF, Fan, C, Perou, CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet
2006; 141B: 261–8.
Takahashi, M, Hayashi, H, Watanabe, Y, Sawamura, K, Fukui, N, Watanabe, J, et al. Diagnostic classification of schizophrenia by neural network analysis of blood-based gene expression signatures. Schizophr Res
2010; 119: 210–8.
Wright, FA, Sullivan, PF, Brooks, AI, Zou, F, Sun, W, Xia, K, et al. Heritability and genomics of gene expression in peripheral blood. Nature Genet
2014; 46: 430–7.